INS and type 2 diabetes mellitus: The treatment of diabetic rats in the T2DM group with Lip-BBR (10 mg/kg b.wt) or Vild (10 mg/kg b.wt) for 14 weeks, on the other hand, significantly (p < 0.0001) reduced serum insulin levels in comparison to the diabetic non-treated group.